Product NDC: | 44206-439 |
Proprietary Name: | Privigen |
Non Proprietary Name: | Human Immunoglobulin G |
Active Ingredient(s): | 40 g/200mL & nbsp; Human Immunoglobulin G |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44206-439 |
Labeler Name: | CSL Behring AG |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA125201 |
Marketing Category: | BLA |
Start Marketing Date: | 20090120 |
Package NDC: | 44206-439-40 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (44206-439-40) > 400 mL in 1 VIAL, GLASS (44206-439-92) |
NDC Code | 44206-439-40 |
Proprietary Name | Privigen |
Package Description | 1 VIAL, GLASS in 1 CARTON (44206-439-40) > 400 mL in 1 VIAL, GLASS (44206-439-92) |
Product NDC | 44206-439 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | Human Immunoglobulin G |
Dosage Form Name | LIQUID |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090120 |
Marketing Category Name | BLA |
Labeler Name | CSL Behring AG |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | 40 |
Strength Unit | g/200mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |